siRNA compounds comprising terminal substitutions
The invention relates to modified siRNA compounds which down-regulate target gene expression, to pharmaceutical compositions comprising such compounds and to methods of treating and/or preventing the incidence or severity of various diseases or conditions associated with the genes and/or symptoms as...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
03.12.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!